<DOC>
	<DOCNO>NCT02536703</DOCNO>
	<brief_summary>To confirm safety efficacy Lotusâ„¢ Valve System Chinese population Transcatheter Aortic Valve Implantation ( TAVI ) symptomatic patient severe aortic stenosis .</brief_summary>
	<brief_title>Safety Efficacy Lotus Valve For TAVI In Patients With Severe Aortic Stenosis In Chinese Population</brief_title>
	<detailed_description />
	<mesh_term>Constriction , Pathologic</mesh_term>
	<mesh_term>Aortic Valve Stenosis</mesh_term>
	<criteria>1 . Patients symptomatic severe aortic stenosis ( echocardiographic criterion : AV effective orifice area ( EOA ) &lt; 1 cm2 , mean AV gradient &gt; 40 mmHg , AV peak systolic velocity &gt; 4.0 m/s ; NYHAclass II great , angina pectoris , syncope ) 2 . Subject informed nature study , agree provision provide write informed consent . 3 . The subject agree comply specify followup evaluation return investigational site procedure perform . 4 . Patients technical anatomical eligible intervention 1 . A known hypersensitivity contraindication follow adequately premedicated : Aspirin Heparin ( HIT/HITTS ) bivalirudin Nitinol ( titanium nickel ) Ticlopidine clopidogrel Contrast medium 2 . Subject refuse blood transfusion . 3 . Other medical , social , psychological condition opinion Investigator precludes subject appropriate consent . 4 . Native aortic annulus size &lt; 20 mm &gt; 29 mm per baseline diagnostic imaging . 5 . Life expectancy less one year</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>